Last reviewed · How we verify
NCT04029142
Screening for Hemoglobinopathies in Pregnant Women
trial testing Review of routine lab data in Hemoglobinopathies in 1,785 participants. Completed in 30 September 2019.
30 September 2019
Quick facts
| Lead sponsor | University Hospital, Basel, Switzerland |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1,785 |
| Start date | 3 July 2019 |
| Primary completion | 30 September 2019 |
| Estimated completion | 30 September 2019 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- Review of routine lab data
Conditions studied
- Hemoglobinopathies — all drugs for Hemoglobinopathies →
Sponsor
University Hospital, Basel, Switzerland
Who can join
Eligibility, female only, with Hemoglobinopathies. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This prospective monocentric study project is to identify hemoglobinopathies in pregnant women in order to optimize antenatal care and to investigate the prevalence of hemoglobinopathies in pregnant women in Switzerland.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Cohort profile: targeted antenatal screening for haemoglobinopathies in Basel.
Amstad Bencaiova G, Geissler F, Hoesli I. · · 2020 · cited 1× · PMID 32699163 · DOI 10.1136/bmjopen-2019-035735
Verify or expand the search:
- PubMed search for NCT04029142
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hemoglobinopathies
Currently open trials in the same condition.
- NCT06872333 — Allo HSCT for High Risk Hemoglobinopathies · Phase 2 · recruiting
- NCT05236764 — Haploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 Depletion · NA · active not recruiting
- NCT06107400 — Safety and Efficacy of RM-004 Cells for Hemoglobin H-Constant Spring Disease · EARLY_PHASE1 · recruiting
- NCT05799118 — Study of the Role of Genetic Modifiers in Hemoglobinopathies · recruiting
- NCT05477563 — Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia an · Phase 3 · recruiting
Other University Hospital, Basel, Switzerland trials
Trials by the same sponsor.
- NCT07444788 — Acute Effects of Intravenous 5-MeO-DMT in Healthy Participants · Phase 1 · recruiting
- NCT07494214 — Acute Analgesic Effects of MDMA on Experimentally Induced Acute Pain, Hyperalgesia and Allodynia in Healthy Participants · Phase 1 · recruiting
- NCT07419048 — Artificial Intelligence or Human Hand? Evaluating Inferior Vena Cava Imaging for Hydration Status · recruiting
- NCT06978777 — Effect of Caffeine on Cold-stimulated Brown Adipose Tissue Activity · NA · recruiting
- NCT07273630 — Effect of Protein Supplementation and Fluid Restriction on Plasma Sodium Levels in Patients Undergoing Pituitary Surgery · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04029142 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Basel, Switzerland
- Last refreshed: 4 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04029142.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing